Maastricht, Netherlands

Manon Adriaan De Bruine

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Manon Adriaan De Bruine: Innovator in Cancer Detection

Introduction

Manon Adriaan De Bruine is a prominent inventor based in Maastricht, Netherlands. She has made significant contributions to the field of cancer detection through her innovative methods and technologies. With a total of five patents to her name, her work focuses on detecting epigenetic modifications that can indicate a predisposition to cancer.

Latest Patents

Her latest patents include compositions for detecting epigenetic modifications. One notable method involves detecting an epigenetic change in specific genes, which can indicate a predisposition to or the incidence of cancer. This method is particularly relevant for gastrointestinal cancers, including colorectal, gastric, and oesophageal cancers. Additionally, her inventions encompass pharmacogenetic methods for determining suitable treatment regimens for cancer patients. These methods aim to improve the collection, processing, and analysis of body fluid samples, enhancing the diagnosis and characterization of various diseases.

Career Highlights

Throughout her career, Manon has worked with notable companies such as Exact Sciences Development Company, LLC and MDxHealth, SA. Her expertise in cancer research and diagnostics has positioned her as a key figure in the field.

Collaborations

Manon has collaborated with esteemed colleagues, including Manon Van Engeland and Arjan Griffioen, to advance her research and innovations in cancer detection.

Conclusion

Manon Adriaan De Bruine's contributions to cancer detection through her innovative patents and collaborations highlight her significant impact in the field. Her work continues to pave the way for advancements in cancer diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…